SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine.

ABSTRACT:

Background

Starting in December 2019, the current pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confronts the world with an unprecedented challenge. With no vaccine or drug being currently available to control the pandemic spread, prevention and PCR (Polymerase chain reaction) testing becomes a crucial pillar of medical systems. Aim of the present study was to report on the first results of the measures taken in a large German Department of Radiation Oncology, including PCR testing of asymptomatic cancer patients.

Methods

Pandemic-adapted hygiene regulations and prevention measures for patients and staff were implemented. A visiting ban on both wards was implemented from the beginning and medical staff and patients were required to wear

SUBMITTER: Marschner S 

PROVIDER: S-EPMC7344028 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature